RE: Dr Alistair Smith interview on Directors Talk25 Jun 2020 11:12
The most lame interviewer who has 3 questions in front of him but never goes in one step deeper... After each response: "hmmm, interesting..." , goes to next question. Wasted opportunity
So I am quite happy with today's RNS. Hochleiter is a conservative prudent character. Him stating that initial signs are "very encouraging" will make me sleep better at night. Stong hold. If I would have been underexposed, I would have said "strong buy". Happy holder
If the test results show it works, you might as well stop investing and leave your shares sitting there. You will have peaked too soon. All the rest would be utter disappointment.
In 12 years of investing, I have never come across a potential like this one. I am 175% up and AVCT is now more than half of the PF. Normally, I'd topslice. This time, I have to just risk it.
Excellent post. The sky is the limit on this one. The benefit of the test? Immediate massive cashflow plus it puts affimers on the map even more than it already was.
Company potentially has key to solution of opening up the world economy. That same company potentially found a treatment as well for this likely reoccurring issue. The testing would open up a market of 10's of billions a year in a matter of months. And you, you use the word "sadly" when stating the testing is months away... and the treatment a few months extra (if it works). Maybe you should invest in a drinks-company that sells their product today. I believe Fevertree is market listed. What a joke...
ARB is a profitable company and is my bet on the future price of BTC. It is very undervalued at the current price, which is why I am in since 3.9p. That does not take away that I have the feeling that the board, the directors and the "consultant"-mates are taking the p!ss with their fees/wages.
I really expect ARB to have a very profitable year ahead. The only item that annoys me a tad is the management remuneration and low priced share options.